TYRVAYA® is the first and only FDA-approved nasal spray for dry eye disease August 6, 2026 Harrow (Nasdaq: HROW) today announced that...
The first and only FDA-approved, incision-free, topical drug therapy for keratoconus March 19, 2026 Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and...
A new eye drop option for treating presbyopia.
A new Ortho-K treatment system option.